Hello, Guest
Login
Sign Up
 
 

Xtremepicks Reports on EKO International (EKNL) News Sparked a Monster Rally Pushing 23.25% Higher

EKNL closed another outstanding session up 23.25% and into solid double digit levels of $0.106. EKNL is revving up it’s engine with solid press releases one after another, and hinting to many more to come

 
 
Repost This

Belize City, Belize -- (SBWIRE) -- 09/27/2012 -- Publishers of daily penny stock newsletter xtremepicks (http://www.xtremepicks.com) looks at EKO International (OTC:EKNL)

Ticker: EKNL
Last Trade: $0.106 +23.25%
Year-to-date High: $0.35
TARGET: $0.50

EKNL closed another outstanding session up 23.25% and into solid double digit levels of $0.106. EKNL is revving up it’s engine with solid press releases one after another, and hinting to many more to come

EKO International Corp – Summary of NeuroVasc Clinical Inc.’s (NVCI) BusinessPR Newswire(Wed 12:20PM EDT)

MAJOR SPECIAL REPORT TO BE RELEASED THIS WEEKEND

Two solid press releases from EKNL prompted xtremepicks to dig real deep into the figures just released on the potential market and will be unleashing a Special Report this weekend that investors definitely do not want to miss - initial price targets may just be too low considering the potential here.

EKNL has it’s hands on a multi-million dollar per year revenue stream adding huge shareholders value.

Each FREMS device can treat approx. 8-10 patients a day. The sale of each FREMS device will generate approx. $ 8,000 of gross profit for EKO Consumable supplies for each treatment will generate approx. $3.00 of gross profit for EKO

Investors already know there are an estimate of 40 Million potential patients with peripheral neuropathy and FREMS is the solution being highly sought after for treatment.

Even penetrating a small % of the market in the initial stages will translate to $10s of millions in gross profits for EKNL. With such a small float of 8 million shares and super low share structure, valuations will be off the charts. Members definitely want to stay tuned for their SPECIAL report this weekend.

EKO International Corp.

EKNL close solid near its HOD at $0.106 up 23.25% and is already showing signs of a major bullish breakout that can triple in value in short order.

Technicals are turning xtremely bullish and a sign that bulls are taking the reign for a monster push higher.

Xtremepicks last 5 picks, CMGO, USEI, AERS, SUTI, and SDSS gave members a potential 3,243%+ gains, EKNL is on the direct path to supersede these gains in a hurry.

CMGO 900%
USEI 1,000%
AERS 900%
SUTI 300%
SDSS 143%

Total Gains 3,243%
Average Gains 650% per pick

FREMS is becoming one of the most sought after product that not only meets rigorous standards safety, but is approved as “safe and effective’ by the FDA!!!

So what is FREMS?

FREMS (Frequency Rhythmic Electrical Modulation System) delivers computer-controlled varied frequencies of electricity through electrodes placed on your skin to stimulate your nerves and blood vessels. Quality research studies have shown that not only are the nerves stimulated to work better (making you feel better), but the small blood vessels so often affected in diabetes, improve their circulation (making you safer and healthier!).

ABOUT EKO INTERNATIONAL
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.

About Xtremepicks.com:
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep informed of the latest movers. Xtremepicks.com penny stock newsletter is the trading connection and remember to always do research, use stop loss orders to protect, and book profits when in a position to do so. Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do own due diligence. Xtremepicks did not receive any compensation for the distribution of this press release. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved.